FHIR CI-Build

This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions

Example ClinicalUseDefinition/example-interaction (Narrative)

Responsible Owner: Biomedical Research and Regulation Work GroupStandards Status: InformativeCompartments: No defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile ClinicalUseDefinition.

Generated Narrative: ClinicalUseDefinition example-interaction

StructureDefinition Work Group: brr

type: Interaction

Subjects

-Reference
* MedicinalProductDefinition: identifier = http://ema.europa.eu/example/MPID#{mpid}; classification = B01AF02

interaction

interactant

item: alphaconazole

interactant

item: betaconazole

type: Inhibitor

Effects

-Concept
* Increased plasma concentration

management: Careful monitoring of dose

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.